IL55227A - Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditions - Google Patents
Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditionsInfo
- Publication number
- IL55227A IL55227A IL55227A IL5522778A IL55227A IL 55227 A IL55227 A IL 55227A IL 55227 A IL55227 A IL 55227A IL 5522778 A IL5522778 A IL 5522778A IL 55227 A IL55227 A IL 55227A
- Authority
- IL
- Israel
- Prior art keywords
- prophylaxis
- amides
- esters
- salts
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C15/00—Butter; Butter preparations; Making thereof
- A23C15/12—Butter preparations
- A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2357578A GB1604554A (en) | 1978-05-26 | 1978-05-26 | Pharmaceutical and food formulations |
| GB2357478 | 1978-05-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL55227A0 IL55227A0 (en) | 1978-09-29 |
| IL55227A true IL55227A (en) | 1982-12-31 |
Family
ID=26256599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL55227A IL55227A (en) | 1978-05-26 | 1978-07-27 | Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditions |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5515444A (en) |
| AU (1) | AU527784B2 (en) |
| CA (1) | CA1151068A (en) |
| CH (1) | CH644267A5 (en) |
| DE (1) | DE2831507A1 (en) |
| ES (1) | ES8104983A1 (en) |
| FR (1) | FR2426461A1 (en) |
| IE (1) | IE48287B1 (en) |
| IL (1) | IL55227A (en) |
| IT (1) | IT1116505B (en) |
| NL (1) | NL191332C (en) |
| NZ (1) | NZ187908A (en) |
| SE (1) | SE448678B (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10383840B2 (en) | 2012-06-29 | 2019-08-20 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| US10449172B2 (en) | 2009-04-29 | 2019-10-22 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US10493058B2 (en) | 2009-09-23 | 2019-12-03 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| US10537544B2 (en) | 2011-11-07 | 2020-01-21 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| US10610508B2 (en) | 2013-02-06 | 2020-04-07 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US10624870B2 (en) | 2009-04-29 | 2020-04-21 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US10668042B2 (en) | 2018-09-24 | 2020-06-02 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
| US10722485B2 (en) | 2013-10-10 | 2020-07-28 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US10842768B2 (en) | 2009-06-15 | 2020-11-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides |
| US10851374B2 (en) | 2013-02-13 | 2020-12-01 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US10888539B2 (en) | 2013-09-04 | 2021-01-12 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US10966951B2 (en) | 2017-05-19 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| US10973796B2 (en) | 2012-01-06 | 2021-04-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| US11141399B2 (en) | 2012-12-31 | 2021-10-12 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US11179362B2 (en) | 2012-11-06 | 2021-11-23 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US11446269B2 (en) | 2014-06-16 | 2022-09-20 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5735512A (en) * | 1980-06-27 | 1982-02-26 | Nippon Oil & Fats Co Ltd | Preventive and remedy for thrombosis |
| JPS59172416A (en) * | 1983-03-18 | 1984-09-29 | Terumo Corp | Fat transfusion solution |
| FR2548021B1 (en) * | 1983-06-29 | 1986-02-28 | Dick P R | PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS |
| CA1239587A (en) * | 1983-10-24 | 1988-07-26 | David Rubin | Combined fatty acid composition for lowering blood cholestrol and triglyceride levels |
| JPS60132916A (en) * | 1983-12-21 | 1985-07-16 | Nisshin Oil Mills Ltd:The | Food or drug for preventing thrombosis |
| US4752618A (en) * | 1984-07-12 | 1988-06-21 | New England Deaconess Hospital | Method of minimizing efects of infection through diet |
| JPH0748991B2 (en) * | 1984-08-29 | 1995-05-31 | 日本油脂株式会社 | Tube feeding composition |
| GB8710780D0 (en) * | 1987-05-07 | 1987-06-10 | Scras | Opthalmological application of eicosapentaenoic acid |
| GB8819110D0 (en) * | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| US5922345A (en) * | 1990-12-07 | 1999-07-13 | Scotia Holdings Plc | Nutrition |
| WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
| NL9401743A (en) * | 1994-10-20 | 1996-06-03 | Prospa Bv | Salts of amino alcohols and pharmaceutical formulations containing them. |
| DE19503993A1 (en) * | 1995-02-08 | 1996-08-14 | Johann Friedrich Dr Med Desaga | Enteral product contg n-3-fatty acid or deriv and medium chain length tri:glyceride |
| DE10056351A1 (en) * | 2000-11-14 | 2002-05-29 | Weylandt Karsten Henrich | Pharmaceutical preparation containing omega-3 fatty acids and other active substances e.g. an antiinflammatory, cyclooxygenase II inhibitor, 5-lipoxygenase inhibitor or platelet aggregation inhibitor |
| GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| KR20150115745A (en) | 2013-02-06 | 2015-10-14 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | Methods for reducing aggregate content in protein preparations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE319677B (en) * | 1965-03-27 | 1970-01-19 | Sumitomo Chemical Co | |
| FR2097036A1 (en) * | 1970-07-29 | 1972-03-03 | Sopharga Lab | Lipids contg fatty acids - for treatment of atheroslerosis |
| GB1476624A (en) * | 1973-05-30 | 1977-06-16 | Cepbepe | Tranquiliser medicaments |
| GB1580444A (en) * | 1976-11-04 | 1980-12-03 | Bio Oil Res | Pharmaceutical compositions |
| JPS6257605A (en) * | 1985-09-05 | 1987-03-13 | Kaizuka Kazutoshi | Method for extracting effective component from multiple-element mineral |
-
1978
- 1978-07-17 AU AU38084/78A patent/AU527784B2/en not_active Expired
- 1978-07-18 DE DE19782831507 patent/DE2831507A1/en active Granted
- 1978-07-19 JP JP8824578A patent/JPS5515444A/en active Pending
- 1978-07-19 NZ NZ187908A patent/NZ187908A/en unknown
- 1978-07-27 IL IL55227A patent/IL55227A/en unknown
-
1979
- 1979-01-19 IT IT47717/79A patent/IT1116505B/en active
- 1979-05-23 FR FR7913122A patent/FR2426461A1/en active Granted
- 1979-05-25 CH CH490379A patent/CH644267A5/en not_active IP Right Cessation
- 1979-05-25 ES ES480921A patent/ES8104983A1/en not_active Expired
- 1979-05-25 SE SE7904570A patent/SE448678B/en not_active IP Right Cessation
- 1979-05-25 NL NL7904144A patent/NL191332C/en not_active IP Right Cessation
- 1979-05-25 CA CA000328419A patent/CA1151068A/en not_active Expired
- 1979-08-08 IE IE1023/79A patent/IE48287B1/en not_active IP Right Cessation
Cited By (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11147787B2 (en) | 2009-04-29 | 2021-10-19 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US10842766B2 (en) | 2009-04-29 | 2020-11-24 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US10449172B2 (en) | 2009-04-29 | 2019-10-22 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US11213504B2 (en) | 2009-04-29 | 2022-01-04 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US10987331B2 (en) | 2009-04-29 | 2021-04-27 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US11033523B2 (en) | 2009-04-29 | 2021-06-15 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same |
| US11103477B2 (en) | 2009-04-29 | 2021-08-31 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US10792267B2 (en) | 2009-04-29 | 2020-10-06 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US10940131B2 (en) | 2009-04-29 | 2021-03-09 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US10888537B2 (en) | 2009-04-29 | 2021-01-12 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising omega-3 fatty acids |
| US11400069B2 (en) | 2009-04-29 | 2022-08-02 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US10624870B2 (en) | 2009-04-29 | 2020-04-21 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US10881632B2 (en) | 2009-04-29 | 2021-01-05 | Amarin Pharmaceuticals Ireland Limited | Stable pharmaceutical composition and methods of using same |
| US11154526B2 (en) | 2009-04-29 | 2021-10-26 | Amarin Pharmaceuticals Ireland Limited | Methods of treating mixed dyslipidemia |
| US11439618B2 (en) | 2009-06-15 | 2022-09-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides |
| US11464757B2 (en) | 2009-06-15 | 2022-10-11 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides |
| US10842768B2 (en) | 2009-06-15 | 2020-11-24 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides |
| US10493058B2 (en) | 2009-09-23 | 2019-12-03 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| US11007173B2 (en) | 2009-09-23 | 2021-05-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| US10632094B2 (en) | 2011-11-07 | 2020-04-28 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US10537544B2 (en) | 2011-11-07 | 2020-01-21 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US10973796B2 (en) | 2012-01-06 | 2021-04-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject |
| US10568861B1 (en) | 2012-06-29 | 2020-02-25 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10792270B2 (en) | 2012-06-29 | 2020-10-06 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10576054B1 (en) | 2012-06-29 | 2020-03-03 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10894028B2 (en) | 2012-06-29 | 2021-01-19 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10555924B2 (en) | 2012-06-29 | 2020-02-11 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10383840B2 (en) | 2012-06-29 | 2019-08-20 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US10555925B1 (en) | 2012-06-29 | 2020-02-11 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease |
| US11229618B2 (en) | 2012-11-06 | 2022-01-25 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US11179362B2 (en) | 2012-11-06 | 2021-11-23 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US11141399B2 (en) | 2012-12-31 | 2021-10-12 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US10675263B2 (en) | 2013-02-06 | 2020-06-09 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US11185525B2 (en) | 2013-02-06 | 2021-11-30 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US10973797B2 (en) | 2013-02-06 | 2021-04-13 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein c-III |
| US10610508B2 (en) | 2013-02-06 | 2020-04-07 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US10851374B2 (en) | 2013-02-13 | 2020-12-01 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| US10888539B2 (en) | 2013-09-04 | 2021-01-12 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US11285127B2 (en) | 2013-10-10 | 2022-03-29 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US10722485B2 (en) | 2013-10-10 | 2020-07-28 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US11052063B2 (en) | 2014-06-11 | 2021-07-06 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| US11446269B2 (en) | 2014-06-16 | 2022-09-20 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| US10842765B2 (en) | 2016-03-15 | 2020-11-24 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| US10966951B2 (en) | 2017-05-19 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| US11116742B2 (en) | 2018-09-24 | 2021-09-14 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
| US11298333B1 (en) | 2018-09-24 | 2022-04-12 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
| US10668042B2 (en) | 2018-09-24 | 2020-06-02 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
| US10786478B2 (en) | 2018-09-24 | 2020-09-29 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
| US11116743B2 (en) | 2018-09-24 | 2021-09-14 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
| US11000499B2 (en) | 2018-09-24 | 2021-05-11 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of cardiovascular events in a subject |
Also Published As
| Publication number | Publication date |
|---|---|
| IE791023L (en) | 1979-11-26 |
| SE448678B (en) | 1987-03-16 |
| FR2426461B1 (en) | 1983-02-11 |
| ES480921A0 (en) | 1981-05-16 |
| CA1151068A (en) | 1983-08-02 |
| IE48287B1 (en) | 1984-11-28 |
| FR2426461A1 (en) | 1979-12-21 |
| NZ187908A (en) | 1984-05-31 |
| CH644267A5 (en) | 1984-07-31 |
| JPS5515444A (en) | 1980-02-02 |
| AU3808478A (en) | 1980-01-17 |
| NL191332B (en) | 1995-01-02 |
| DE2831507C2 (en) | 1989-07-13 |
| NL191332C (en) | 1995-06-01 |
| IT7947717A0 (en) | 1979-01-19 |
| NL7904144A (en) | 1979-11-28 |
| DE2831507A1 (en) | 1979-11-29 |
| SE7904570L (en) | 1979-11-27 |
| AU527784B2 (en) | 1983-03-24 |
| IT1116505B (en) | 1986-02-10 |
| ES8104983A1 (en) | 1981-05-16 |
| IL55227A0 (en) | 1978-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL55227A (en) | Pharmaceutical compositions comprising(all-z)-5,8,11,14,17-eicosapentaenoic acid or its salts,esters or amides for the treatment and prophylaxis of thromboembolic conditions | |
| GB2033745B (en) | Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions | |
| GB2221843B (en) | Fatty acid composition | |
| GB2052505B (en) | Treatment of phosphorus acid salts and compositions produced thereby | |
| RO76614A (en) | PROCESS FOR THE PREPARATION OF 3,4-DEHYDROPROLINE AND 4,5-DEHYDROPIPECOLIC ACID DERIVATIVES | |
| PT71028A (en) | Process for the preparation of azolyloxy-carboxylic acid amides with herbicidal-effect | |
| IL52023A (en) | Process for the preparation of di-n-propyl-acetic acid and salts thereof | |
| ATA387777A (en) | Process for the preparation of the novel 17,18- dehydroapovincaminol and its acid addition salts | |
| DE3062140D1 (en) | Process for the preparation of n-alpha-alkoxyalkyl carboxylic acid amides, some representatives of these compounds, and their ensuing products | |
| IL61210A (en) | 3-benzoyl-2-nitrophenylacetic acids and metal salts,amides and esters thereof and pharmaceutical compositions containing them | |
| NZ195058A (en) | 2b-acetoxymethyl-(5r)-2-methyl-penam-3-carboxylic acid 1, 1-dioxide and salts and esters thereof pharmaceutical compositions | |
| ZA792043B (en) | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them | |
| PT78939B (en) | Process for preparing esters of pantetheine and pantethine with 3-pyridineacetic or 3-(3-pyridylmethoxycarbonyl)-propionic acid and of pharmaceutical compositions containing the same | |
| HUT38321A (en) | Herbicide compositions containing substituted carboxylic acid anilides as active substances and process for preparing the active substances | |
| DE2967551D1 (en) | 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them | |
| RO77326A (en) | PROCESS FOR THE PREPARATION OF PHOSPHORIC AND THIONOPHOSPHONIC ESTERS OF 5 (3) -HYDROXYPYRAZOLES | |
| RO76126A2 (en) | PROCESS FOR THE PREPARATION OF ANTHRAQUINONE-2,6 AND 2,7-OESULPHONIC ACIDS | |
| DE3161125D1 (en) | Process for the preparation of o,o-disubstituted benzoic acids and their salts | |
| IL60281A (en) | Process for the preparation of(phenoxy-or benzyl-)-phenoxypropionic acids and their alkali metal salts | |
| RO69679A (en) | PROCESS FOR THE PREPARATION OF AMIDES OF PHOSPHORIC ACID ESTERS | |
| IL63440A (en) | Process for the manufacture of 3-acylazo-propionic acid esters and isomers thereof and their use for the preparation of alkyl 1,2,3-thiadiazole 5-carboxylates | |
| PT70367A (en) | Process for the preparation of 4,4-dimethyl-4-sila-fatty acid amides with pharmaceutical effect | |
| BE894154A (en) | PROCESS FOR THE PREPARATION OF ALKOXYVINCAMINIC AND ALKOXYAPOVINCAMINIC ACID ESTERS | |
| IL52966A0 (en) | Novel 2-(phenylalkylhydrazono)-propionic acid derivatives process for their preparation and pharmaceutical compositions containing the same | |
| IL50982A (en) | (5-alkylureido-1,3,4-thiadiazol-2-yl-thio)-acetic acid esters,process for the preparation of said compounds and herbicidal compositions containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed |